PSR2 EVALUATING THE POTENTIAL COST-EFFECTIVENESS OF FUTURE ANTICOAGULANT DRUGS VS. WARFARIN IN THE PREVENTION OF STROKE AND MAJOR BLEEDS IN ATRIAL FIBRILLATION PATIENTS

May 1, 2005, 00:00 AM
10.1016/S1098-3015(10)62879-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)62879-3/fulltext
Section Title :
Section Order : 315
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62879-3&doi=10.1016/S1098-3015(10)62879-3
HEOR Topics :
Tags :
Regions :